Pfizer will be able to provide the United States with 200 million doses of the COVID-19 vaccine it developed alongside BioNTech by the end of May, CEO Albert Bourla said Tuesday, per Bloomberg. That's two months ahead of the previous July 31 deadline the company had set for itself.
The reason for the apparent fast-tracking is actually a Food and Drug Administration-approved label change, which went into effect Monday, allowing health care workers to extract an additional sixth dose from each vial, so production levels won't necessarily increase. Bourla also said the alteration means Pfizer will be able to deliver 120 million doses to the U.S. by the end of March, 20 million more than promised when the vaccine was initially granted emergency use.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Superboys of Malegaon: 'uplifting' Indian love letter to scrappy filmmakingThe Week Recommends 'Feelgood' comedy about a group of friends who make their own versions of Bollywood hits
-
The week's best photosIn Pictures Rio’s dirtiest party, a pancake-flipping race, and more
-
Properties of the week: residences for croquet enthusiastsThe Week Recommends Featuring homes in Devon, Dorset and Oxfordshire
-
Texas outbreak brings 1st US measles death since 2015Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
-
Mystery illness spreading in Congo rapidly kills dozensSpeed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
